Best KRAS, NRAS,BRAF mutation testing doctors: TOP 41 doctors

The doctor is a highly experienced Turkish medical oncologist specializing in sarcoma, lymphoma, pancreatic, lung cancer, and breast cancer. With over 20 years of experience, the doctor focuses on tumor biology, tumor immunology, cancer immunotherapy, and targeted therapies. Since 2019, the doctor has been serving as a medical oncologist at Anadolu Medical Center and previously held leadership roles at Istanbul Okan University Faculty of Medicine and GATA Haydarpaşa Training Hospital. The doctor has authored over 40 publications in cancer research and is a member of the Turkish Medical Oncology Association and the European Head and Neck Society.

The doctor is a highly regarded oncologist at the Anadolu Medical Center, specializing in medical oncology and chemotherapy. After obtaining a medical degree from Ankara University in 2005, the doctor completed specialty training in internal medicine at Istanbul University and further specialized in medical oncology at Marmara University by 2017. The doctor has led the medical oncology unit at Haydarpaşa Numune Training and Research Hospital and has participated in numerous international clinical studies. The doctor focuses on a wide range of cancers, including breast, urological, lung, and gastrointestinal cancers, among others.

The doctor is a member of several prestigious oncology societies, including the Turkish Society of Medical Oncology, the European Society of Medical Oncology, and the American Society of Medical Oncology. The doctor has participated in advanced training programs globally, including programs at Oxford University and ESMO.

The doctor graduated from the School of Medicine at Hacettepe University and completed residency at Istanbul Sisli Etfal Training and Research Hospital, followed by a fellowship at the Hacettepe University Cancer Institute.

Specializing in oncology, the doctor has extensive experience in treating various cancers, including breast, testicular, ovarian, lung, head and neck, and gastrointestinal cancers.

The doctor has worked at prestigious institutions such as The University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.

The doctor graduated from Istanbul University, Istanbul Medicine Faculty in 2007 and completed a specialization in surgery at Sisli Etfal Education and Research Hospital in 2013. Further advancing their expertise, they joined the General Surgery Clinic at Istanbul Okan University in 2020.

With extensive experience in various medical institutions, the doctor has worked at Sisli Hamidiye Etfal Training and Research Hospital, Siverek State Hospital, and Anadolu Medical Center. They are a member of several prestigious organizations, including the European Society of Coloproctology and the Turkish Surgical Society.

The doctor holds numerous certifications, such as the Turkish Surgical Association Qualification Certificate and has completed advanced courses in endoscopy, bariatric surgery, and laser techniques for hemorrhoidal diseases.

Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.

Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."

In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

The doctor serves as the Chief Physician of the Otolaryngology, Head and Neck Surgery, and Plastic Surgery Departments at Solingen Clinic in Germany. Specializing in the sparing treatment of tumors in the head, neck, and upper airways, the doctor employs advanced techniques such as endoscopic operations through the nose and robotic interventions with incisions as small as 1 cm.

With over 11 years of surgical experience, the doctor is also an accomplished academic, contributing to 78 scientific publications. The doctor completed medical studies in the USA and Germany, and has held significant roles in various German medical institutions.

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

The doctor specializes in managing breast cancer, colorectal, and urogenital system cancers. With extensive experience since 2014 at Anadolu Medical Center, the doctor has previously served at Medical Park Hospital, Kocaeli Derince Education and Research Hospital, and Erzurum Regional Education and Research Hospital. The doctor's military service included a role as a Medical Oncology specialist at Gülhane Military Medical Academy.

Educational achievements include a degree in general medicine from Istanbul University and specializations in internal medicine and medical oncology. The doctor is a member of the Turkish Medical Association, the Turkish Medical Oncology Society, and the Turkish Lung Cancer Society.

The doctor is an ECFMG and ESMO-certified medical and breast oncologist with over 20 years of experience, specializing in solid cancer, breast cancer, colorectal, and lung cancer treatment. Since 2016, the doctor has been a medical oncology specialist at Anadolu Medical Center.

The doctor graduated from Gülhane Military Medical Academy with a degree in general medicine and completed specialties in internal and medical oncology. The doctor has been a professor and associate professor at Gülhane Military Medical Academy, contributing significantly to medical education.

With over 110 papers on cancer management, the doctor is a member of several prestigious oncology organizations.

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

The doctor graduated from Ankara University Medical School and completed residency training in internal medicine at Ankara GATA Medical School. Specializing in medical oncology and hematology, the doctor completed a clinical fellowship in the USA. A pioneer in Turkey, the doctor was part of the team that performed the first bone marrow transplantation in the country. The doctor has served as a visiting lecturer at prestigious institutions in London and Switzerland. Holding the European Medical Oncology Certificate, the doctor is a founding member of both The Turkish Society of Medical Oncology and the Turkish Oncology Group. The clinical focus includes breast, gastrointestinal, lung cancers, lymphomas, and myeloma.

Known Expertise 

Medical Oncologist 

Academic Position 

Senior Lecturer 

Education

Bar-Ilan University, Israel / Computational Biology 

Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech 

Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics 

Semmelweis University/Doctor of Medicine 

Training and Specialization 

Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England 

Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center 

Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech 

Resident, Medical Oncology, TASMC, Israel 

6th year medical school rotations, Kaplan Medical Center, Israel 

Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US 

Clinical Experience 

Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative 

PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC. 

PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC. 

Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO 

Consultant on drugs and operations in the field of oncology, Leumit HMO 

Member of the Helsinki Committee for Clinical Studies, TASMC 

Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel 

Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society 

NGS interpretation clinic alongside head of pathology, TASMC, Israel 

PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel 

Medical oncology clinic in the field of lung and breast cancer, TASMC, Israel

Leading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel 

Courses 

Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course 

Point-of-Care Ultrasound course, Israeli Medical Association 

GCP training Bioforum 

GCP training Bioforum

Investigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma 

Academic Experience 

Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University 

JIMS Journal Club - Instructor for students. 

Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations. 

TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA 

Training team for oncology residents, TASMC, Israel 

Mentor for new intern, TASMC, Israel 

Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel 

Honors 

Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel

 Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel 

Sign of honor for reserve medical personnel for the battle in Lebanon, IDF

Completion of residency final examination (shlav Beit) with honors 

Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner 

Affiliations 

Israeli Medical Association (IMA) 

Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT) 

The Israeli Lung Cancer Group (ILCG) 

European Society of Medical Oncology (ESMO) 

International Association for the Study of Lung Cancer (IASLC) 

The International Society of Liquid Biopsy (ISLB) 

The Israeli Society for Health-Tech 

Boards 

Co-founder, board member and treasurer of the Israeli Acute Oncology Society 

Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group 

Member of the Trustees of Oncology Innovation, TASMC, Israel 

Doctor of Medical Service IDF 

Areas of interest 

Thoracic malignancies, 

early to late phase clinical trials, 

intra-tumoral injections, 

comprehensive genomic profiling of tumors, 

liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics; 

cell therapy

The doctor is a leading figure in medical oncology, hematology, and cancer immunotherapy, with a career spanning over four decades. After earning a medical degree from the University of Vienna in the 1970s, the doctor completed specialist training in internal medicine and oncology in the 1980s.

In the 1990s, the doctor was appointed Head of the Clinical Division of Oncology at the Medical University of Vienna, leading Austria's largest oncology department. The 2000s saw the founding of the Comprehensive Cancer Center Vienna, integrating patient care, research, and education.

The doctor served as President of the Central European Cooperative Oncology Group in the 2010s and currently holds positions as Chairman of the Vienna Cancer Center and Medical Director of Wiener Privatklinik’s International Oncology Center.

Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.

She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.

Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020